Gerhild Wildner was born in Graz, Austria, has studied biology at the University of Cologne, Germany, and received a diploma in genetics/immunology in 1982. In 1987, she received her Ph.D. degree in immunology from the Ludwig-Maximilians-University of Munich, Germany. During her postdoctorates from 1987 to 1991 at the Max-Planck-Institute for Biochemistry in Martinsried, Germany, she worked on DNA mismatch repair and molecular biology of hepatitis B viruses. In 1991, she founded the Section of Immunobiology at the Department of Ophthalmology of the Ludwig-Maximilians-University. Since then, she focuses on the pathomechanisms of intraocular inflammatory diseases (antigenic mimicry, mechanisms of relapsing-remitting autoimmune diseases) and development of new therapeutic strategies (oral tolerance induction with autoantigen mimotopes) in the rat model of experimental autoimmune uveitis (EAU). She is a Professor of immunology and Consultant Immunologist at the German Society for Immunology (DGfI). She currently works at Clinic of the Ludwig-Maximilians-University of Munich, Germany. In 2000, she cofounded the Munich Collaborative Research Center SFB 571 “Autoimmune reactions: From manifestations and mechanisms to therapy". In 2004, she received the Research Award of the Deutsche Vereinigung Morbus Bechterew (DVMB), became Sponsor of the Orphan Drug "HLA-B27-derived peptide (amino acid 125-138) for the treatment of autoimmune uveitis" at the EMEA in 2005, and was a Member of the Council Boards of IOIS and SOIE (International Societies of Ocular Inflammation) as well as a Member of the ARVO Awards Committee. She has joined the Editorial Board of Journal of Autoimmune Diseases and is the Guest Editor of Current Immunology Reviews.
Biography Updated on 18 April 2011